Ashley David
Family · Glen Mills, PANPI 1144777848
Payments from drug & device makers
Across 62 payments — averaging $16.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$338
- Novo Nordisk$119
- Boehringer Ingelheim$98
- Merck$67
- Adlon Therapeutics L.p.$65
- Biohaven Pharmaceuticals, Inc.$59
- plus $291 from 12 others
What the payments were for
- Food & beverage$1,038100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 23 | $338 |
| Novo Nordisk | 7 | $119 |
| Boehringer Ingelheim | 5 | $98 |
| Merck | 4 | $67 |
| Adlon Therapeutics L.p. | 3 | $65 |
| Biohaven Pharmaceuticals, Inc. | 3 | $59 |
| Teva Pharmaceuticals USA, Inc. | 2 | $53 |
| Kowa Pharmaceuticals America, Inc. | 3 | $43 |
| Amarin Pharma, Inc. | 2 | $36 |
| Amgen | 1 | $26 |
| Johnson & Johnson | 2 | $24 |
| Daiichi Sankyo Inc. | 1 | $23 |
| AstraZeneca | 1 | $20 |
| Nestle Healthcare Nutrition Inc. | 1 | $18 |
| Eyevance Pharmaceuticals LLC | 1 | $18 |
| Lilly USA, LLC | 1 | $14 |
| Orexo US, Inc. | 1 | $12 |
| Genentech USA, Inc. | 1 | $3 |
How this compares
$1,038 in reported general payments places this provider in the 70th percentile of 4,717 family providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 33 | $772 |
| Rosuvastatin Calcium | 29 | $522 |
| Atorvastatin Calcium | 21 | $277 |
| Lisinopril | 21 | $226 |
| Amlodipine Besylate | 39 | $224 |
| Omeprazole | 12 | $169 |
| Levothyroxine Sodium | 15 | $168 |
| Metoprolol Succinate | 17 | $150 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 18 | $138 |
| Losartan Potassium | 11 | $129 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 30 | $122 |
| Doxycycline Hyclate | 28 | $102 |
| Fluticasone Propionate | 11 | $100 |
| Clonazepam | 12 | $69 |
| Prednisone | 32 | $69 |
Paid to pharmacies, not to this prescriber.
Other family in Glen Mills
- Kathleen ScholzPittsburgh$397K
- Shannon FitzgeraldAllison Park$370K
- Stephanie HarshbargerCamp Hill$317K
- Whitney BowlesFort Washington$253K
- Kweilynn GreenePittsburgh$139K
- Jessica LindenbergerPittsburgh$131K
- Kami NestlerWilkes Barre$129K
- Bethany ThomasPhiladelphia$126K
- Margaret RosenzweigPittsburgh$89K
- Amanda GrippoDickson Cty$86K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.